Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- LABS.TO
- Price
- 0.09
- Stock movement up
- +0.01 (6.25%)
- Company name
- Medipharm Labs Corp
- Exchange
- (TO ,
- Currency
- CAD )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 34.95M
- Ent value
- 31.19M
- Price/Sales
- 0.93
- Price/Book
- 0.73
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -5.03%
- 1 year return
- -
- 3 year return
- -16.31%
- 5 year return
- -43.90%
- 10 year return
- -
Last updated: 2025-04-12
DIVIDENDS
LABS.TO does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.93 |
| Price to Book | 0.73 |
| EV to Sales | 0.83 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 411.12M |
| EPS (TTM) | -0.03 |
| FCF per share (TTM) | -0.01 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 37.76M |
| Gross profit (TTM) | 10.68M |
| Operating income (TTM) | -13.92M |
| Net income (TTM) | -13.49M |
| EPS (TTM) | -0.03 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 28.28% |
| Operating margin (TTM) | -36.87% |
| Profit margin (TTM) | -35.72% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 15.99M |
| Net receivables | 6.22M |
| Total current assets | 37.92M |
| Goodwill | 0.00 |
| Intangible assets | 943.00K |
| Property, plant and equipment | 42.34M |
| Total assets | 59.84M |
| Accounts payable | 2.65M |
| Short/Current long term debt | 2.81M |
| Total current liabilities | 12.18M |
| Total liabilities | 12.23M |
| Shareholder's equity | 47.61M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -4.45M |
| Capital expenditures (TTM) | 456.00K |
| Free cash flow (TTM) | -5.26M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -28.33% |
| Return on Assets | -22.54% |
| Return on Invested Capital | -26.77% |
| Cash Return on Invested Capital | -10.44% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.09 |
| Daily high | 0.09 |
| Daily low | 0.08 |
| Daily Volume | 75K |
| All-time high | 7.17 |
| 1y analyst estimate | 0.10 |
| Beta | 0.92 |
| EPS (TTM) | -0.03 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 15 May 2025 |
Downside potential
Loading...
Downside potential data
| LABS.TO | S&P500 | |
| Current price drop from All-time high | -98.81% | -12.89% |
| Highest price drop | -99.23% | -56.47% |
| Date of highest drop | 25 Jul 2023 | 9 Mar 2009 |
| Avg drop from high | -80.58% | -11.07% |
| Avg time to new high | 53 days | 12 days |
| Max time to new high | 1425 days | 1805 days |
COMPANY DETAILS
Marketcap
34.95M
Marketcap category
Small-cap
Description
MediPharm Labs Corp., a pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis products. In addition, the company offers cannabis related medical information and services; and medical cannabis clinic services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.
Employees
166
Investor relations
-
SEC filings
CEO
Country
Canada
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, today announced its fi...
March 31, 2025
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce...
March 26, 2025
The Canadian market has been navigating a landscape of uncertainty, with recent tariff threats and political ambiguities influencing investor sentiment. Amidst these challenges, investors often look f...
March 13, 2025
The Canadian market is navigating a complex landscape, with tariffs posing potential risks to economic growth and inflation. Despite these challenges, opportunities for investors remain, particularly ...
February 10, 2025
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company") has terminated the previously announced sale of its facility in Napanee, Ontario (the "Napanee Facility...
February 10, 2025
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company") is pleased to provide an update with respect to the previously announced sale of its facility in Napane...
January 16, 2025
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm" or the "Company"), a leader in pharmaceutical-grade cannabis manufacturing, is proud to announce a commercial agreement with Laboratório Te...
January 8, 2025
The Canadian market has recently experienced a pullback, with the TSX index losing about 6.5% since its peak in December, reflecting uncertainties in political leadership and policy shifts. Despite th...
December 23, 2024
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company") and Kensana Health Inc. ("Kensana Health") are pleased to announce that they have entered into a share ...
December 17, 2024
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids announced its financial...
November 14, 2024
Next page